Venous Thromboembolism and Cancer
A New Focus for Better Patient Outcomes

The International Initiative on Thrombosis and Cancer (ITAC), the international section of the Groupe Francophone Thrombose et Cancer (GFTC), presents this educational platform for specialist physicians and nurses involved in the care of patients with cancer who are at risk of venous thromboembolism (VTE) or with established VTE, including central venous catheter-related thrombosis (CRT).

Learn more about ITAC-CME

In the news

Moving the Needle:

Cancer Associated Thrombosis

Tuesday, March 2, 2021

The International Society on Thrombosis and Haemostasis (ISTH) and the International Initiative on Thrombosis and Cancer (ITAC-CME) announce the launch of new educational modules “Moving the Needle: Cancer Associated Thrombosis”. The series includes three distinct modules addressing: Primary Prophylaxis (Module 1), Module 2: Non-CRT VTE (Module 2), and Module 3: CRT VTE (Module 3). 

Join Dominique Farge-Bancel, MD, Jean M. Connors, MD, and James Douketis, MD, FRCPC, FACP, FCCP, FCAHS as they provide education to hematologists and oncologists to support guideline-recommended care of patients with cancer, specifically related to appropriate VTE prophylaxis and patient-centered, individualized VTE treatment. 

The program can be accessed on the ISTH Academy website

 



In 2018 and 2019, the development and maintenance of the ITAC website was supported by the following pharmaceutical companies:

These funding sources have had no influence on the content of the site, for which editorial independence is guaranteed.